Fractional anisotropy predicts which mutation carriers convert to clinical frontotemporal dementia


  • Fractional anisotropy can predict conversion to symptomatic disease within 4 years in presymptomatic frontotemporal dementia mutation carriers.

Why this matters

    Up to 20% of frontotemporal dementia is caused by pathogenic mutations, but there is no reliable tool to predict which mutation carriers will experience clinical conversion. These findings enable more accurate conversion prediction for genetic frontotemporal dementia which could provide psychological benefits and better future care.

Want to read more?

Log in or sign up to access all Neurodiem content.

Already have an account? Log In

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.